Body Fluids Modulate Propagation of Tumor Treating Fields

Overview

Journal Adv Radiat Oncol

Specialty Oncology

Date 2024 Jan 23

PMID 38260214

Authors

Eric T Wong

Edwin Lok

Affiliations

Soon will be listed here.

Abstract

Tumor treating fields (TTFields) are nonionizing alternating electric fields that have anticancer properties. After the initial approval for use in patients with recurrent glioblastoma in 2011 and newly diagnosed glioblastomas in 2015, they are now being tested in those with advanced lung cancer, ovarian carcinoma, and pancreatic cancer. Unlike ionizing radiation therapy, TTFields have nonlinear propagation characteristics; therefore, it is difficult for clinicians to recognize intuitively the location where these fields have the most impact. However, finite element analysis offers a means of delineating TTFields in the human body. Our analyses in the brain, pelvis, and thorax revealed that cerebrospinal fluid, edema, urine, ascites, pleural fluid, and necrotic core within a tumor greatly influence their distribution within these body cavities. Our observations thus provided a unified framework on the role of these compartmentalized fluids in influencing the propagation of TTFields.

References

Lok E, San P, Hua V, Phung M, Wong E . Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma. Cancer Med. 2017; 6(6):1286-1300. PMC: 5463092. DOI: 10.1002/cam4.1095. View

Lok E, Hua V, Wong E . Computed modeling of alternating electric fields therapy for recurrent glioblastoma. Cancer Med. 2015; 4(11):1697-9. PMC: 4673996. DOI: 10.1002/cam4.519. View

Voloshin T, Munster M, Blatt R, Shteingauz A, Roberts P, Schmelz E . Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo. Int J Cancer. 2016; 139(12):2850-2858. PMC: 5095795. DOI: 10.1002/ijc.30406. View

Pinkawa M, Asadpour B, Siluschek J, Gagel B, Piroth M, Demirel C . Bladder extension variability during pelvic external beam radiotherapy with a full or empty bladder. Radiother Oncol. 2007; 83(2):163-7. DOI: 10.1016/j.radonc.2007.03.015. View

Timmons J, Lok E, San P, Bui K, Wong E . End-to-end workflow for finite element analysis of tumor treating fields in glioblastomas. Phys Med Biol. 2017; 62(21):8264-8282. DOI: 10.1088/1361-6560/aa87f3. View

Liebeskind D, Juttler E, Shapovalov Y, Yegin A, Landen J, Jauch E . Cerebral Edema Associated With Large Hemispheric Infarction. Stroke. 2019; 50(9):2619-2625. DOI: 10.1161/STROKEAHA.118.024766. View

Lok E, Liang O, Malik T, Wong E . Computational Analysis of Tumor Treating Fields for Non-Small Cell Lung Cancer in Full Thoracic Models. Adv Radiat Oncol. 2023; 8(4):101203. PMC: 10196273. DOI: 10.1016/j.adro.2023.101203. View

Lok E, Swanson K, Wong E . Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations. Expert Rev Med Devices. 2015; 12(6):717-26. DOI: 10.1586/17434440.2015.1086641. View

Jones T, Song J, Abushahin L . Tumor treating fields: An emerging treatment modality for thoracic and abdominal cavity cancers. Transl Oncol. 2021; 15(1):101296. PMC: 8633677. DOI: 10.1016/j.tranon.2021.101296. View

10.

Chen D, Le S, Hutchinson T, Calinescu A, Sebastian M, Jin D . Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma. J Clin Invest. 2022; 132(8). PMC: 9012294. DOI: 10.1172/JCI149258. View

11.

Bomzon Z, Urman N, Wenger C, Giladi M, Weinberg U, Wasserman Y . Modelling Tumor Treating Fields for the treatment of lung-based tumors. Annu Int Conf IEEE Eng Med Biol Soc. 2016; 2015:6888-91. DOI: 10.1109/EMBC.2015.7319976. View

12.

Henderson F, Abdullah K, Verma R, Brem S . Tractography and the connectome in neurosurgical treatment of gliomas: the premise, the progress, and the potential. Neurosurg Focus. 2020; 48(2):E6. PMC: 7831974. DOI: 10.3171/2019.11.FOCUS19785. View

13.

Verbalis J . Brain volume regulation in response to changes in osmolality. Neuroscience. 2010; 168(4):862-70. DOI: 10.1016/j.neuroscience.2010.03.042. View

14.

Chen V, Gillespie E, Manger R, Skerritt L, Tran J, Proudfoot J . The impact of daily bladder filling on small bowel dose for intensity modulated radiation therapy for cervical cancer. Med Dosim. 2018; 44(2):102-106. DOI: 10.1016/j.meddos.2018.02.010. View

15.

Gera N, Yang A, Holtzman T, Lee S, Wong E, Swanson K . Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit. PLoS One. 2015; 10(5):e0125269. PMC: 4444126. DOI: 10.1371/journal.pone.0125269. View

16.

Kaal E, Vecht C . The management of brain edema in brain tumors. Curr Opin Oncol. 2005; 16(6):593-600. DOI: 10.1097/01.cco.0000142076.52721.b3. View

17.

Yang G, Chen S, Kinouchi H, Chan P, Weinstein P . Edema, cation content, and ATPase activity after middle cerebral artery occlusion in rats. Stroke. 1992; 23(9):1331-6. DOI: 10.1161/01.str.23.9.1331. View

18.

Basser P, Pierpaoli C . Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. 1996. J Magn Reson. 2011; 213(2):560-70. DOI: 10.1016/j.jmr.2011.09.022. View

19.

Korshoej A, Hansen F, Thielscher A, von Oettingen G, Sorensen J . Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study. PLoS One. 2017; 12(6):e0179214. PMC: 5467909. DOI: 10.1371/journal.pone.0179214. View

20.

Moiseenko V, Liu M, Kristensen S, Gelowitz G, Berthelet E . Effect of bladder filling on doses to prostate and organs at risk: a treatment planning study. J Appl Clin Med Phys. 2007; 8(1):55-68. PMC: 5722405. DOI: 10.1120/jacmp.v8i1.2286. View